SMSarah E. Maurrasse

Sarah E. Maurrasse

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sarah E. Maurrasse has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • In Response to Safety Profile of Nebulized Ciprofloxacin‐Dexamethasone After Pediatric Airway Surgery

    by Abbey L. Landini, Cyrus W. Abrahamson, Maya Frost, David Spielberg, Inbal Hazkani, Dana M. Thompson, Jonathan B. Ida, Sarah Maurrasse, Taher Valika

  • Open Access

    Safety Profile of Nebulized Ciprofloxacin‐Dexamethasone After Pediatric Airway Surgery

    by Abbey L. Landini, Cyrus W. Abrahamson, Maya Frost, David Spielberg, Inbal Hazkani, Dana M. Thompson, Jonathan B. Ida, Sarah Maurrasse, Taher Valika

    Objective: To evaluate the safety profile and patterns of use of nebulized ciprofloxacin–dexamethasone (CPD) in pediatric patients undergoing airway surgery. Methods: A retrospective chart review was performed of patients who underwent airway surgery at a tertiary pediatric center between 2019 and 2023 and received nebulized CPD 0.3%–0.1% postoperatively. Demographic, clinical, and procedural data were extracted. Exposure was defined as any postoperative nebulized administration. Adverse events were considered potentially CPD‐related if they occurred during administration or within 30 days of discontinuation without a better explanation. Outcomes included endocrine, metabolic, infectious, pulmonary, and inflammatory complications. Results: A total of 399 patients received nebulized CPD. Mean age was 46.2 months (range: newborn–20.7 years). Indications included subglottic stenosis (92.5%), post‐laryngotracheal reconstruction (5.3%), airway foreign body (2.0%), and supraglottoplasty (0.3%). Comorbidities were frequent, including neurologic conditions (47.6%), cardiac anomalies (41.6%), and bronchopulmonary dysplasia (25.1%). Most patients (93.4%) received CPD in the inpatient setting, for a mean duration of 11.7 days. No cases of adrenal suppression, glucose abnormalities, or bronchial hyperreactivity were identified. One patient had suspected airway fungal infection while receiving chemotherapy, though pathology was negative. Among the 85.7% of patients who underwent postoperative endoscopic evaluation, no significant inflammatory findings were observed. Conclusion: Nebulized CPD Was Uniformly Incorporated Into Postoperative Airway Management in This Large Pediatric Cohort and Well Tolerated, With no Significant Adverse Events Observed. These Findings Support the Safety of CPD in Medically Complex Children and Highlight the Need for Multicenter Prospective Studies to Evaluate Efficacy and Optimize Dosing Protocols. Level of Evidence: 3


  • Producing a High‐Quality Surgical Video

    by Sarah E. Maurrasse, Vikash K. Modi

    Producing high-quality surgical videos requires an understanding of cognitive theory and a working knowledge of film principles. In this editorial, we delve into pre-production, filming, and editing fundamentals that help create a professional product and highlight techniques to optimize knowledge acquisition through video content. image

  • Open Access

    The Airway Pocket: Novel Advancement in Endoscopic Submucosal Placement of Posterior Cartilage Graft

    by Taher Valika, Christopher Mularczyk, Diane Chen, Sarah Maurrasse, Michael Gorelik

    Endoscopic technology has increased our options for treatment of airway stenosis in a minimally invasive manner. This novel technique advances endoscopic posterior graft placement by creation of an airway pocket, potentially reducing risk of graft migration and improving outcomes. Laryngoscope, 2024.


  • Anatomy of the Neonatal Airway

    by Sarah E. Maurrasse, Erik H. Waldman

  • Assessing National Trends and Perceived Safety of Off‐Label Ciprofloxacin‐Dexamethasone Use by Pediatric Otolaryngologists

    by Hemali P. Shah, Rema Shah, Donovan Lockwood, Nan Yang, Tagan Rohrbaugh, Michael J. Rutter, Sarah E. Maurrasse

    Objectives: Off‐label use of Ciprodex® (ciprofloxacin‐dexamethasone: CPD), an antibiotic‐steroid combination solution, in the airway has been reported by pediatric otolaryngologists with anecdotal success. We examined national trends regarding off‐label CPD use including prevalence, common indications, prescriber patterns, adverse events, and accessibility. Methods: 15‐item cross‐sectional survey was distributed to American Society of Pediatric Otolaryngology members from January–April 2022. Univariate analyses were performed to compare responses for users of off‐label CPD versus non‐users. Ease of access was compared across geographies and practice types using multivariate logistic regressions. Results: Of the 163 complete responses (26.6% response rate), 156 (95.7%) reported using off‐label CPD. Most common indications for off‐label CPD were tracheal granulation (87.8%, n = 137) and choanal atresia (82.1%, n = 128). Ease of access was significantly increased in the Midwest (OR:18.79, 95%CI:3.63–1.24, p = 0.001) and West (OR:29.92, 95%CI:3.55–682.00, p = 0.006). Ease of access was significantly lower at tertiary referral centers (OR:0.11, 95%CI:0.01–0.64, p = 0.041) and private practices (OR:0.04, 95%CI:0.002–0.33, p = 0.009) compared to academic free‐standing children's hospitals. Two‐thirds of respondents reported feeling “Very Comfortable” with the safety profile of off‐label CPD; 99.4% ( n = 156) felt that the benefits outweighed the risks of off‐label use. Seven respondents (4.5%) reported adverse events (e.g., local allergic reaction, cushingoid symptoms) from off‐label use. Conclusions: Our findings (26.6% response rate) suggest that off‐label CPD is commonly used by pediatric otolaryngologists, many of whom reported feeling that the benefits of off‐label CPD outweigh the risks. Our results establish a baseline for future efforts to assess the efficacy and safety of off‐label CPD and to improve its accessibility. Level of Evidence: V Laryngoscope , 134:2922–2930, 2024


  • Type 3 Laryngeal Clefts Presenting with Upper Airway Obstruction without Aspiration

    by Rachel E. Weitzman, Hemali P. Shah, Vikash K. Modi, Sarah E. Maurrasse

    Traditionally, otolaryngologists are taught that the defining clinical feature of a laryngeal cleft is aspiration. However, in a small subset of patients—even those with extensive clefts—the sole presenting feature may be airway obstruction. Here, we report two cases of type III laryngeal clefts that presented with upper airway obstruction without aspiration. The first patient was a 6‐month‐old male with history of tracheoesophageal fistula (TEF) who presented with noisy breathing, initially thought to be related to tracheomalacia. Polysomnogram (PSG) demonstrated moderate OSA and modified barium swallow (MBS) was negative for aspiration. In‐office laryngoscopy was notable for a mismatch of tissue in the interarytenoid region. A type III laryngeal cleft was identified on bronchoscopy, and airway symptoms resolved after endoscopic repair. The second patient was a 4‐year‐old male with a diagnosis of asthma who presented with progressive exercise‐induced stridor and airway obstruction. In‐office flexible laryngoscopy revealed redundant tissue in the posterior glottis and MBS was negative for aspiration. He was found to have a type III laryngeal cleft on bronchoscopy and his stridor and upper airway obstruction resolved after endoscopic repair. While aspiration is the most common presenting symptom of a laryngeal cleft, it is important to consider that patients can have a cleft in the absence of dysphagia. Laryngeal cleft should be included in the differential diagnosis for patients with obstructive symptoms not explained by other etiologies and in those with suspicious features on flexible laryngoscopy. Laryngeal cleft repair is recommended to restore normal anatomy and relieve obstructive symptoms. Laryngoscope, 134:977–980, 2024

  • Open Access

    An uncommon presentation of a parotid salivary duct cyst in a child

    by Craig Cameron Brawley, Sarah E. Maurrasse, Monica Aldulescu, John Maddalozzo


  • Open Access

    Unilateral vocal cord paralysis due to meningoencephalitis in a pediatric patient

    by Rachel Hall, Sarah E. Maurrasse, Alok I. Jaju, Douglas R. Johnston